Stockscreener 앱 받기
12.21
1.54%
0.185
전일 마감가:
$12.02
열려 있는:
$11.78
하루 거래량:
5,008
Relative Volume:
0.26
시가총액:
$8.13M
수익:
-
순이익/손실:
$-24.05M
주가수익비율:
-5.6767
EPS:
-2.15
순현금흐름:
$-17.78M
1주 성능:
+13.17%
1개월 성능:
+31.24%
6개월 성능:
-55.63%
1년 성능:
-87.81%
1일 변동 폭
$11.78
$12.50
1주일 범위
$10.21
$12.85
52주 변동 폭
$8.67
$196.70
Envveno Medical Corporation Stock (NVNO) Company Profile
명칭
Envveno Medical Corporation
전화
949-261-2900
주소
70 DOPPLER, IRVINE
Compare NVNO vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NVNO
Envveno Medical Corporation
|
12.40 | 7.88M | 0 | -24.05M | -17.78M | -2.15 |
|
ABT
Abbott Laboratories
|
110.36 | 192.10B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
343.92 | 137.25B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
89.16 | 115.41B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.28 | 103.81B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
84.44 | 49.82B | 6.07B | 1.06B | 1.34B | 1.8063 |
Envveno Medical Corporation 주식(NVNO)의 최신 뉴스
enVVeno Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement - Independent Mail
NorthStrive Fund II LP Calls on enVVeno Medical to Halt Clinical Spending Plans and Call Special Shareholder Meeting to Vote on Strategic Alternatives - The Manila Times
Reviewing Pressure BioSciences (OTCMKTS:PBIO) & enVVeno Medical (NASDAQ:NVNO) - Defense World
NVNO SEC FilingsEnvveno Medical Corporation 10-K, 10-Q, 8-K Forms - Stock Titan
NVNO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Can enVVeno Medical Corporation maintain sales growthQuarterly Profit Summary & Daily Growth Stock Tips - baoquankhu1.vn
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
enVVeno Medical (NVNO) investor urges halt to trials, strategic review - Stock Titan
enVVeno Medical Announces Reverse Stock Split - Press & Sun-Bulletin
Perceptive funds hold 2.05M enVVeno (NVNO) shares and warrants - Stock Titan
NVNO Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Strategic Investor Acquires Significant Stake in enVVeno Medical - AD HOC NEWS
Investor Braeden Lichti discloses 5.05% enVVeno (NVNO) ownership stake - Stock Titan
Aug Analyst Calls: Is enVVeno Medical Corporation a strong candidate for buy and hold2025 Risk Factors & Short-Term High Return Ideas - baoquankhu1.vn
Head to Head Analysis: LENSAR (NASDAQ:LNSR) versus enVVeno Medical (NASDAQ:NVNO) - Defense World
enVVeno Receives Unfavorable Appeal Decision from the FDA for the VenoValve - The Northwest Florida Daily News
enVVeno Medical (NASDAQ:NVNO) to Participate in a Live Virtual Investor CEO Connect Segment - DelmarvaNow.com
enVVeno Medical Regains Nasdaq Compliance, Supports 2026 Plans - The Globe and Mail
EnVVeno Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement - News Channel Nebraska Southeast
enVVeno Medical regains Nasdaq compliance, reports $28 million cash By Investing.com - Investing.com Nigeria
enVVeno Medical regains compliance with Nasdaq minimum bid price rule - TipRanks
enVVeno Medical Regains Nasdaq Compliance - Orange County Business Journal
enVVeno Medical regains Nasdaq compliance, reports $28 million cash - Investing.com
Bank Watch: Is enVVeno Medical Corporation a strong candidate for buy and hold2025 Performance Recap & Smart Investment Allocation Tips - baoquankhu1.vn
enVVeno Medical Reports Third Quarter 2025 Financial Results and Provides Corporate Update - Green Bay Press-Gazette
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Breakout Zone: Why is Pliant Therapeutics Inc stock going upJuly 2025 Macro Moves & Expert Verified Stock Movement Alerts - baoquankhu1.vn
Volume Report: Will enVVeno Medical Corporation benefit from seasonalityShort Setup & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Envveno Medical Corporation (NVNO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.61%
1.39%
자본화:
|
볼륨(24시간):